What should you know about IDH wildtype glioblastoma?

Wildtype means the tested IDH1 or IDH2 gene did not show the change being assessed. This wording is a laboratory description, not a symptom and not a complete explanation of the tumour. The specialist team also considers tissue appearance, grade, imaging, tumour position, and other molecular findings.

Glioblastoma symptoms vary with the area affected. They may include a seizure, headache, weakness, speech or vision changes, or problems with thinking and balance. A report should be discussed with the team that has access to the scans and the tissue sample.

Care may involve [Brain Tumour Surgery] when removal or tissue sampling can be done safely, followed by [Radiotherapy], [Chemotherapy], symptom-control medicines, rehabilitation, or a combined approach. Decisions depend on the tumour’s position, how much can be removed, neurological function, pathology, and personal priorities. A [Clinical Trials] conversation may be useful if an appropriate option is available.

Ask for a copy of the pathology report and scan summary. Clarify the treatment goal, likely appointment pattern, seizure precautions, and which team member should handle urgent questions.

Seek emergency help for a first seizure, a prolonged seizure, sudden weakness or numbness, new speech trouble, collapse, or severe confusion. Call the hospital promptly for a rapidly worsening headache with repeated vomiting, new severe drowsiness, fever after surgery, wound discharge, or a sudden decline in walking or vision.

Was IDH1, IDH2, or both assessed? Which other molecular results are available? What do the scans and pathology show? What is the purpose and timing of surgery, radiotherapy, or chemotherapy? Is a clinical trial suitable? What is the emergency plan for seizures or new neurological symptoms?